Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Murine class I major histocompatibility complex H-2Dd: expression, refolding and crystallization.

A Achour1, R A Harris, K Persson

  • 1Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden.

Acta Crystallographica. Section D, Biological Crystallography
|March 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Getting to the <em>heart</em> of the matter: diagnostic tools and therapeutic approach to cardiac involvement in Behçet syndrome A Tunisian case series.

Reumatismo·2021
Same author

Short- and long-term follow-up of living kidney donors.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2019
Same author

Summaries of the papers of the 4th National Congress of the Tunisian Society of Medical Oncology attached to the 4th Maghreb Congress of Oncology.

La Tunisie medicale·2018
Same author

Recombinant human erythropoietin prevents etoposide- and methotrexate-induced toxicity in kidney and liver tissues via the regulation of oxidative damage and genotoxicity in Wistar rats.

Human & experimental toxicology·2017
Same author

Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord.

Bone marrow transplantation·2017
Same author

[A multicenter study on profile of hypertension in focal segmental glomerulosclerosis in Tunisia].

Annales de cardiologie et d'angeiologie·2015

Researchers crystallized a soluble murine H-2Dd major histocompatibility complex. This complex, bound to beta2 microglobulin and an HIV-1 peptide, was successfully crystallized for structural analysis.

Area of Science:

  • Structural biology
  • Immunology
  • Biochemistry

Background:

  • Major histocompatibility complex (MHC) class I molecules present peptide antigens to T cells.
  • Understanding MHC-peptide interactions is crucial for immunology and vaccine development.
  • The murine H-2Dd complex is a model system for studying antigen presentation.

Purpose of the Study:

  • To obtain a soluble, functional H-2Dd complex for structural studies.
  • To crystallize the H-2Dd complex in association with a specific peptide antigen.
  • To characterize the crystal structure of the H-2Dd-peptide complex.

Main Methods:

  • Cloning and expression of a truncated soluble H-2Dd in Escherichia coli.
  • In vitro refolding of the expressed protein with murine beta2 microglobulin.

Related Experiment Videos

  • Co-crystallization with the RGPGRAFVTI peptide derived from HIV-1 gp160.
  • X-ray diffraction analysis of the obtained crystals.

    • Main Results:

    • Successfully produced and refolded a soluble H-2Dd-beta2 microglobulin complex.
    • Obtained crystals of the complex with the HIV-1 V3-loop peptide.
    • Crystals belonged to space group P212121 with specific cell dimensions.
    • Diffraction data extended to at least 2.4 Å resolution.

    Conclusions:

    • The study provides a structural basis for understanding H-2Dd-restricted T cell recognition.
    • The crystallized complex serves as a valuable resource for further structural and functional investigations.
    • This work facilitates the design of targeted immunotherapies and vaccines.